Luxembourg
As part of our ongoing regulatory intelligence monitoring, we identified a key update on the santesecu.public.lu website: the first edition of the Pharmacovigilance (PV) Bulletin was published by Santé publique Luxembourg on 26 March 2025.
This bulletin was created as a reaction to the results of a survey on healthcare professionals’ perception of pharmacovigilance. The findings highlighted the need for improved communication and awareness around drug safety, prompting the Pharmacovigilance team and the Division of Medicines and Pharmacy (DPM) to develop and launch a dedicated Pharmacovigilance bulletin.
What’s in the first edition?
- Introduction and definition of Pharmacovigilance
- Guidance on how to report adverse reactions – MedSafetyWeek highlights, promoting healthcare professionals’ commitment to PV
- A retrospective overview of PV activities in Luxembourg in 2024
We will continue to monitor future editions and related updates as part of our regular surveillance of official regulatory sources.
More information about this PV bulletin can be found here: https://santesecu.public.lu/fr/publications/b/bulletin-information-pharmaco-01.html